Clinical Trials Logo

Recurrent Lymphoma, Mantle-Cell clinical trials

View clinical trials related to Recurrent Lymphoma, Mantle-Cell.

Filter by:
  • None
  • Page 1

NCT ID: NCT02419560 Suspended - Clinical trials for Lymphoma, Mantle-Cell

Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL

Start date: April 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the optimal dosing scheme for the combination of ibrutinib with ABT-199 for the treatment of relapsed or refractory mantle cell lymphoma (MCL).